Thailand FDA Issues Guidelines for Clinical Trials During COVID-19 Outbreak
June 12, 2020
On May 26, 2020, Thailand's Food and Drug Administration issued guidance to sponsors and investigators regarding the conduct of clinical trials during the COVID-19 outbreak. The guidelines provide examples of flexible approaches to ensure participant safety while still complying with good clinical practices and maintaining data integrity. (Google translation of guidelines)